• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Igc Pharma Inc (NY: IGC )

    0.3899 -0.0089 (-2.23%)
    Official Closing Price Updated: 8:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Igc Pharma Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    AI And THC: IGC Pharma Teams Up With Colombian University For Alzheimer's Treatment Research
    IGC Pharma partners with University of Los Andes, to leverage AI for improving Alzheimer's disease treatment and clinical trial efficiency. 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Enters Strategic Collaboration to Advance AI Initiatives
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives
    From IGC Pharma, Inc.
    Via Business Wire
    InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Q2 2024 Financial, Corporate Report
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    IGC Pharma Reports Second Quarter Fiscal 2024 Results
    From IGC Pharma, Inc.
    Via Business Wire
    Cannabis Based Pain Relief Solution Receives European Patent Approval
    IGC Pharma, Inc. (NYSE American: IGC) has been granted European Patent No. 3193862 by the European Patent Office for its innovative "Cannabinoid Composition and Method for Treating Pain." 
    Via Benzinga
    Topics Cannabis Intellectual Property
    Exposures Cannabis Intellectual Property
    InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Cannabinoid-Based Topical Pain-Relief Treatment Receives European Patent
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    IGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy
    From IGC Pharma, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    420 with CNW — Study Suggests Marijuana Users Are Less Predisposed to Type 2 Diabetes
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — Study Suggests Marijuana Users Are Less Predisposed to Type 2 Diabetes
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    BioMedNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Announces Results of Annual Meeting
    Via Investor Brand Network
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    IGC Announces Results of its 2023 Annual Stockholders Meeting
    From IGC Pharma, Inc.
    Via Business Wire
    420 with CNW — AMA Study Finds Marijuana Smoking Viewed as Safer Than Cigarette Smoking
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — AMA Study Finds Marijuana Smoking Viewed as Safer Than Cigarette Smoking
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — LA Mayor to Announce Head of City Marijuana Agency
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — LA Mayor to Announce Head of City Marijuana Agency
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — Gallup Poll Finds Highest Ever Support for Cannabis Legalization Among Republicans
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — Gallup Poll Finds Highest Ever Support for Cannabis Legalization Among Republicans
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — Cannabis Industry Lobbying Increases as Looming Government Shutdown Leaves SAFE Banking in Balance
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — Cannabis Industry Lobbying Increases as Looming Government Shutdown Leaves SAFE Banking in Balance
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — CNN’s Dr. Gupta Discusses Marijuana Use by Seniors
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — CNN’s Dr. Gupta Discusses Marijuana Use by Seniors
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    BioMedNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Q1 2024 Financial Report
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials
    From IGC Pharma, Inc.
    Via Business Wire
    420 with CNW— Study Finds Workplace Accident Rates No Different Between Off-Duty Marijuana Users and Non-Users
    Via CannabisNewsWire
    Topics Cannabis
    Exposures Cannabis
    420 with CNW— Study Finds Workplace Accident Rates No Different Between Off-Duty Marijuana Users and Non-Users
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    420 with CNW — Indoor MJ Growers Give Insights into How Preharvest Care Can Optimize Yields
    Via Investor Brand Network
    Topics Cannabis
    Exposures Cannabis
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.